BIORCHESTRA Announces 45 Million USD Series C Fundraising

/PRNewswire/ -- BIORCHESTRA is a leading RNA therapeutics company whose lead programs focus on neurodegenerative diseases using its proprietary RNA-based drug...

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,United States ,United Kingdom ,Massachusetts ,Boston ,Daejeon ,Taejon Gwangyoksi ,Cambridge ,Cambridgeshire ,Korea ,Louis Odea ,Young Gil Kim ,Branden Jinhyeob Ryu ,Chong Kun Dang ,Co Ltd ,Leaders World Congress ,Therapeutics Delivery Us Congress ,Chong Kun Dang Holdings ,Formulation Delivery United Kingdom Congress ,Seriesc Fundraising ,Daily Partners ,Smilegate Investment ,Quantum Ventures Korea ,Stick Investment ,Chong Kun Dang Pharmaceutical ,Amyotrophic Lateral Sclerosis ,Louiso Dea ,Gil Kim ,Quickfire Challenge ,Clinical Trial ,World Congress ,Based Therapeutics Conference ,Delivery United Kingdom Congress ,Modalities Summit ,Biorchestra Co ,Td ,